These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 10519585

  • 1. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.
    Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW.
    Ophthalmology; 1999 Oct; 106(10):1915-23. PubMed ID: 10519585
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
    Kramer M, Miller JW, Michaud N, Moulton RS, Hasan T, Flotte TJ, Gragoudas ES.
    Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
    [Abstract] [Full Text] [Related]

  • 4. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
    Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA.
    Retina; 2001 Mar; 21(5):493-8. PubMed ID: 11642379
    [Abstract] [Full Text] [Related]

  • 5. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization.
    Husain D, Miller JW, Michaud N, Connolly E, Flotte TJ, Gragoudas ES.
    Arch Ophthalmol; 1996 Aug; 114(8):978-85. PubMed ID: 8694734
    [Abstract] [Full Text] [Related]

  • 6. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid.
    Kim IK, Husain D, Michaud N, Connolly E, Lane AM, Durrani K, Hafezi-Moghadam A, Gragoudas ES, O'Neill CA, Beyer JC, Miller JW.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):357-63. PubMed ID: 16384985
    [Abstract] [Full Text] [Related]

  • 7. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ, Terada Y, Haddadin MJ, Michaud NA, Gragoudas ES, Miller JW.
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [Abstract] [Full Text] [Related]

  • 8. Ocular changes after photodynamic therapy.
    Tzekov R, Lin T, Zhang KM, Jackson B, Oyejide A, Orilla W, Kulkarni AD, Kuppermann BD, Wheeler L, Burke J.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):377-85. PubMed ID: 16384988
    [Abstract] [Full Text] [Related]

  • 9. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
    Schlötzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U.
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
    [Abstract] [Full Text] [Related]

  • 10. Problems with and pitfalls of photodynamic therapy.
    Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi DM.
    Ophthalmology; 2000 Jan; 107(1):29-35. PubMed ID: 10647715
    [Abstract] [Full Text] [Related]

  • 11. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
    Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples.
    Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, Zografos L, Birngruber R, van den Bergh H, Strong A, Manjuris U, Fsadni M, Lane AM, Piguet B, Bressler NM.
    Graefes Arch Clin Exp Ophthalmol; 1998 May; 236(5):365-74. PubMed ID: 9602321
    [Abstract] [Full Text] [Related]

  • 13. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
    Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, Flotte TJ, Haimovici R, Gragoudas ES.
    Arch Ophthalmol; 1995 Jun; 113(6):810-8. PubMed ID: 7540388
    [Abstract] [Full Text] [Related]

  • 14. Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).
    Miller JW.
    Trans Am Ophthalmol Soc; 2008 Jun; 106():357-82. PubMed ID: 19277246
    [Abstract] [Full Text] [Related]

  • 15. The chorioretinal damage caused by different half parameters of photodynamic therapy in rabbits.
    Chuang LH, Hwang YS, Wang NK, Chen YP, Liu L, Yeung L, Chen KJ, Chen TL, Wu WC, Lai CC.
    J Ocul Pharmacol Ther; 2014 Oct; 30(8):642-9. PubMed ID: 24949836
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
    Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F.
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
    [Abstract] [Full Text] [Related]

  • 17. Benefits and complications of photodynamic therapy of papillary capillary hemangiomas.
    Schmidt-Erfurth UM, Kusserow C, Barbazetto IA, Laqua H.
    Ophthalmology; 2002 Jul; 109(7):1256-66. PubMed ID: 12093647
    [Abstract] [Full Text] [Related]

  • 18. BDNF reduces the retinal toxicity of verteporfin photodynamic therapy.
    Paskowitz DM, Nune G, Yasumura D, Yang H, Bhisitkul RB, Sharma S, Matthes MT, Zarbin MA, Lavail MM, Duncan JL.
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4190-6. PubMed ID: 15505074
    [Abstract] [Full Text] [Related]

  • 19. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
    Odergren A, Ming Y, Kvanta A.
    Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
    [Abstract] [Full Text] [Related]

  • 20. Choroidal and Retinal Changes After Systemic Adrenaline and Photodynamic Therapy in Non-Human Primates.
    Cheong KX, Barathi VA, Teo KYC, Chakravarthy U, Tun SBB, Busoy JM, Ho CEH, Agrawal R, Takahashi K, Cheung CMG.
    Invest Ophthalmol Vis Sci; 2021 Mar 01; 62(3):25. PubMed ID: 33729474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.